Smith Mary L.
SEC Form 4 insider trading activity
Smith Mary L. has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jul 13, 2026.
On the most recent filing, Smith Mary L. is listed as Director at PTC THERAPEUTICS, INC. Inside the rolling window, Smith Mary L. reported no open-market purchases and 1 open-market sale totaling $1.4M in PTCT.
Companies traded
Other insiders at PTCT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Smith Mary L. made?
Smith Mary L. has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Smith Mary L. trade?
Smith Mary L. has filed SEC Form 4 disclosures for 1 company, including PTCT.
When was Smith Mary L.'s most recent SEC Form 4 filing?
Smith Mary L.'s most recent SEC Form 4 filing on Tracefour is dated Jul 13, 2026.
What is Smith Mary L.'s total buy and sell value in the current window?
Inside the rolling retention window, Smith Mary L. bought $0 and sold $1.4M based on SEC Form 4 filings.
What was Smith Mary L.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,834 PTCT shares on 2026-07-09, worth $1.4M, per SEC Form 4 filings.